Find a Heart Failure LVAD Clinic
Need help finding an LVAD clinic near you? Our LVAD clinic finder will connect you with an advanced heart failure care team in your area.
Abbott has been a leader in heart pump technology for more than 20 years. You should feel confident with a HeartMate 3™ LVAD to treat your heart failure. Here's why:
Abbott’s heart pumps have set the standard in LVAD therapy. The HeartMate 3 LVAD is the most advanced LVAD yet. It is the only LVAD that uses a patented technology which helps protect the blood as it flows through the pump.
In the largest LVAD clinical trial* ever conducted, HeartMate 3 LVAD had outstanding clinical results and a high survival rate similar to heart transplant 2 years after surgery.1,2+
Heart failure has devastating consequences in the United States and while the average age of patients is much higher, it can affect the lives of children and their families. For many types of pediatric heart failure patients, receiving a heart transplant is the gold standard in care. While waiting for a heart transplant, some children may require a left ventricular assist device (LVAD) to support their heart until a donor heart is available. In addition, children who are not current candidates for heart transplantation may receive an LVAD to allow the child to resume a sense of normal life.
Watch this video to learn about HeartMate 3 LVAD therapy and how it can help people with advanced heart failure.
Associated risks of LVAD therapy can include bleeding, stroke, thrombosis and other possible adverse events.
This testimonial relates an account of an individual’s response to the treatment. This patient’s account is genuine, typical and documented. However, it does not provide any indication, guide, warranty or guarantee as to the response other persons may have to the treatment. Responses to the treatment discussed can and do vary and are specific to the individual patient.
Abbott collaborated with the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) to advocate the importance of the HeartMate 3 LVAD as a life-saving resource for some of their most vulnerable patients.
Learn more about the ACTION Learning Network and explore additional resources.
These materials are not intended to replace your doctor’s advice or information. For any questions or concerns you may have regarding the medical procedures, devices and/or your personal health, please discuss these with your physician.
* A clinical trial is a type of research that studies a test or treatment given to people.
+ 82% 2-year survival for adult heart transplant patients between 2009 and 2015.
Results based on published data from multicenter experience and separate studies, which may involve different patient populations and other variables. Not a head-to-head comparison. Data presented for informational purposes only.
MAT-2108557 v4.0
